Isotretinoin Difa

Isotretinoin, the active ingredient in Isotretinoin Difa, is a retinoid presented as an oral dosage form for oral use. It is employed to treat severe, recalcitrant nodular acne in patients who have not responded to conventional therapies.

GNH USA supplies Isotretinoin Difa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin is a retinoid indicated for severe forms of acne that involve the pilosebaceous unit. - Severe recalcitrant nodular acne: markedly reduces inflammatory lesions and prevents new nodule formation. - Severe acne vulgaris: improves overall skin clearance when topical agents are insufficient. - Cystic acne: decreases cyst development and promotes long‑term remission.

Isotretinoin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry skin and mucous membranes: increased dryness of skin, lips, and eyes. - Cheilitis: painful cracking of the lips. - Elevated liver enzymes: mild transaminase rise detectable on labs. - Hypertriglyceridemia: rise in blood triglyceride levels. - Headache: occasional tension‑type headaches. - Photosensitivity: heightened skin reaction to sunlight.

Serious or Rare Side Effects: - Teratogenicity: severe birth defects if exposure occurs during pregnancy. - Depression or suicidal ideation: mood alterations requiring immediate evaluation. - Inflammatory bowel disease: rare onset or exacerbation of Crohn's disease or ulcerative colitis. - Pancreatitis: acute inflammation of the pancreas, often linked to high triglycerides. - Severe hypercalcemia: rare calcium metabolism disturbance.

Isotretinoin requires careful monitoring due to its potency and risk profile. - Pregnancy contraindication: must not be used by pregnant women or women planning pregnancy. - Contraception requirement: reliable birth control is mandatory for females of child‑bearing potential. - Liver function monitoring: periodic liver enzyme tests are advised. - Lipid profile monitoring: check triglycerides and cholesterol regularly. - Avoid vitamin A supplements: excess retinoids increase toxicity risk. - Store below 25°C: keep in the original packaging, protect from moisture and direct light.

Isotretinoin can interact with several drug classes, altering safety or efficacy.

Major Interactions (Avoid): - Tetracyclines: combined use raises risk of intracranial hypertension. - Vitamin A supplements or other retinoids: additive toxicity, especially hepatotoxicity. - Systemic corticosteroids: may exacerbate mood disturbances.

Moderate Interactions (Monitor Closely): - Oral contraceptives: isotretinoin may reduce contraceptive effectiveness; additional methods advised. - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may lower isotretinoin plasma levels. - Lipid‑lowering agents (e.g., fibrates): monitor triglycerides for additive hyperlipidemia.